Replies to post #137339 on Biotech Values

[nivasvs]

"Any comments on a glucokinase activator for T2D?"

I don't have any comment specific to GKA.

However, my biggest concern with drugs that target liver is safety issues, such as elevated liver enzymes. I have seen same problem with GCGR, however, excellent glucose lowering was.